Studio Investment Management LLC Accustem Sciences Inc. Transaction History

Studio Investment Management LLC

  • $455 Million
  • Q4 2024

A detailed history of Studio Investment Management LLC transactions in Accustem Sciences Inc. stock. As of the latest transaction made, Studio Investment Management LLC holds 30 shares of ACUT stock, worth $8. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Holding current value
$8
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.22 - $0.45 $6 - $13
30 New
30 $0

Others Institutions Holding ACUT

# of Institutions
1
Shares Held
30
Call Options Held
0
Put Options Held
0
View Full List

About Accustem Sciences Inc.

ACUT Quotes by TradingView
  • Ticker ACUT
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two cli...
More about ACUT
Track This Portfolio

Track Studio Investment Management LLC Portfolio

Follow Studio Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Studio Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Studio Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email